SCHEMBL20428340

SCHEMBL20428340

COc1ccc(N(C)c2cc(=O)oc3ccccc23)cc1OS(C)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 5/20 0.40
HPGD P15428 4/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HSD17B10 Q99714 3/20 0.40
CYP3A4 P08684 2/20 0.40
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GLA P06280 1/20 0.40
ABCB1 P08183 1/20 0.40
THRB P10828 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 3/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
NPC1 O15118 3/20 0.40
MAOA P21397 6/20 0.39
CYP2A6 P11509 1/20 0.39
LMNA P02545 3/20 0.38
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20428404 0.90 MEN1 (0.49) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL20420749 0.83 L3MBTL1 (0.47) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL20428400 0.83 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL20420735 0.82 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL20420770 0.82 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL31005008 0.81 NQO1 (0.49) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL20420753 0.81 CA12 (0.48) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL20420720 0.81 NQO1 (0.49) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL20428284 0.81 ACHE (0.45) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL20420797 0.81 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3354648-A1 4-SUBSTITUED COUMARIN DERIVATIVE, AND PREPARATION METHOD AND USE THEREOF Guizhou Bailing Group Pharmaceutical Co., Ltd. (CN) 2018-08-01 EP disclosed